$Medpace (MEDP.US)$Revenue, operating profit, and net profit...

2023Q1 revenue increased by 31.2%, operating profit increased by 34.3%, and net profit increased by only 18.9% due to income tax fluctuations.

The balance ratio has risen from 39% to 71.4% in the past 5 years. The accounts receivable ratio and growth rate are normal, and there is no inventory.

Goodwill of 700 million dollars is double the net assets of 347 million, and the asset content is very low.

Short-term loans have been growing rapidly recently, which may be the impact of excessive business growth on the increase in working capital requirements.

The share capital has been declining, indicating that the company directly cancelled the shares after buying back them, which is very beneficial to increasing earnings per share.

Over the past five years, net cash flow from operations has been far higher than net investment, and there is a lot of shareholder surplus.

Currently, the price-earnings ratio is 33.6, and the price-earnings ratio TTM has dropped to 31.2. You can choose (⭐️⭐️)